Shubhendu Sen Roy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shubhendu sen roy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shubhendu Sen Roy Today - Breaking & Trending Today

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to the Cyclacel Pharmaceuticals First Quarter 2023 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. ....

United Kingdom , Paul Mcbarron , Mark Kirschbaum , Shubhendu Sen Roy , Spiro Rombotis , Ladenburg Thalmann , Exchange Commission , National Cancer Institute On Unsplash , Health Photo , Cyclacel Pharmaceuticals First Quarter , Securities Exchange , Cyclacel Pharmaceuticals Inc , Cyclacel Pharmaceuticals , Call Transcript May , Conference Call , Private Securities Litigation Reform Act , Securities Exchange Act , Chief Executive Officer , Executive Vice President , Chief Operating Officer , Senior Vice President , Chief Medical , National Cancer Institute , Chief Medical Officer , Ahu Demir , Brookline Capital ,

SCYNEXIS, Inc. (SCYX) Q3 2022 Earnings Call Transcript

SCYNEXIS, Inc. (NASDAQ:NASDAQ:SCYX) Q3 2022 Results Conference Call November 9, 2022 08:30 AM ET Company Participants Debbie Etchison - Communications & IR Dr. ....

United States , Louise Chen , Debbie Etchison , Marco Taglietti , Shubhendu Sen Roy , Michael Higgins , David Angulo , Ivor Macleod , Exchange Commission , Company Participants , Ladenburg Thalmann , World Health Organization , Scynexis Inc , Conference Call November , Sen Roy , Executive Director , Risk Factors , Chief Medical Officer , Chief Financial Officer , Chief Executive , Chief Financial , Brookline Capital ,

Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q1 2022 Results - Earnings Call Transcript

Oncternal Therapeutics, Inc (NASDAQ:NASDAQ:ONCT) Q1 2022 Earnings Conference Call May 5, 2022, 5:00 PM ET Company Participants James Breitmeyer – President & Chief Executive Officer. ....

United States , Dana Farber Cancer Institute , San Diego , Kumar Raja , Carl Byrnes , James Breitmeyer , Hartaj Singh , Kaveri Pohlman , Shubhendu Sen Roy , Shubhendu Sen Kumar , Jim Breitmeyer , Salim Yazji , Richard Vincent , Vincent Salim Yazji , Brian Petitt , Company Participants , American Society Of Clinical Oncology Meeting , California Institute For Regenerative Medicine , Karolinska Institute , National Institutes Of Health , Oncternal Therapeutics Inc , Oncternal Therapeutics Inc Third Quarter , Uc San Diego School Of Medicine , Oncternal Therapeutics , Conference Call May , Chief Executive ,